About
BridGene Biosciences is a biotechnology company dedicated to discovering novel targets and developing new therapeutics for unmet medical needs. BridGene is applying its IMTAC platform to discover druggable opportunities across the entire proteome. With IMTAC, BridGene is able to expand the therapeutic applications of small molecules drugs to a wider range of fields.